Pharma rates and value Retailers: Sudip Bandyopadhyay Downies Market Outlook

The pharmaceutical sector of India may not be in the headlines, but tariff -related uncertainties remain an important care for investors, says MarktExpert Sudip Bandyopadhyay. “Rate is the greatest uncertainty. Apart from Sun Pharma, most companies are not affected by the current American tariff regime. Even Sun will even avoid the bullet with recent developments. […]